scispace - formally typeset
S

Sang Ok Kwon

Researcher at Yonsei University

Publications -  86
Citations -  2555

Sang Ok Kwon is an academic researcher from Yonsei University. The author has contributed to research in topics: Cirrhosis & Portal hypertension. The author has an hindex of 27, co-authored 85 publications receiving 2313 citations. Previous affiliations of Sang Ok Kwon include Konkuk University.

Papers
More filters
Journal ArticleDOI

Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study

TL;DR: In experimental models, bone marrow‐derived mesenchymal stem cells have the capacity to differentiate into hepatocytes and exhibit antifibrotic effects, but there have been no studies in humans with alcoholic cirrhosis.
Journal ArticleDOI

Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension.

TL;DR: Histological subclassification of cirrhosis by the Laennec fibrosis scoring system is tightly correlated with both the clinical stage of cir rhosis and grade of portal hypertension, suggesting that Cirrhosis should be subclassified into different stages according to its histological severity.
Journal ArticleDOI

The role of endoscopic retrograde pancreatography in the treatment of traumatic pancreatic duct injury.

TL;DR: Early ERP is one of the most useful methods for demonstrating MPD injury and assists with treatment planning based on the degree of pancreatic duct injury, according to patients who underwent ERP earlier.
Journal ArticleDOI

Acute hemodynamic effects of octreotide and terlipressin in patients with cirrhosis: a randomized comparison

TL;DR: Results suggest that terlipressin may have more sustained hemodynamic effects in patients with bleeding varices, compared with octreotide, which only transiently reduced portal pressure and flow, whereas the effects of ter Lipressin were sustained.

Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction{A figure is presented}

TL;DR: It was demonstrated that an obstruction across the cystic duct orifice by tumor and the presence of gallbladder stone were risk factors for the development of cholecystitis after metal stent placement.